Ovarian Serous Cystadenocarcinoma: Mutation Analysis (MutSig)
Maintained by Dan DiCara (Broad Institute)
Overview
Introduction

This report serves to describe the mutational landscape and properties of a given individual set, as well as rank genes and genesets according to mutational significance. MutSig vS2N was used to generate the results found in this report.

  • Working with individual set: OV

Input

The input for this pipeline is a set of individuals with the following files associated for each:

  1. An annotated .maf file describing the mutations called for the respective individual, and their properties.

  2. A .wig file that contains information about the coverage of the sample.

Summary
Results
Significantly Mutated Genes

Column Descriptions:

  • N = number of sequenced bases in this gene across the individual set

  • nnon = number of (nonsilent) mutations in this gene across the individual set

  • nnull = number of (nonsilent) null mutations in this gene across the individual set

  • nflank = number of noncoding mutations from this gene's flanking region, across the individual set

  • nsil = number of silent mutations in this gene across the individual set

  • p = p-value (overall)

  • q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)

Table 1.  Get Full Table A Ranked List of Significantly Mutated Genes. Number of significant genes found: 54. Number of genes displayed: 35. Click on a gene name to display its stick figure depicting the distribution of mutations and mutation types across the chosen gene (this feature may not be available for all significant genes).

gene N nflank nsil nnon nnull p q
TP53 39816 0 3 279 101 0 0
BRCA1 224044 0 0 12 11 1.7e-83 1.6e-79
KCNJ12 45504 0 2 5 0 4e-34 2.5e-30
BRCA2 421544 0 0 12 10 1.5e-27 7e-24
CDK12 147256 0 0 9 5 4.6e-23 1.7e-19
FAM171B 93220 0 0 7 1 6.7e-15 2.1e-11
PXN 40764 0 0 5 0 9.5e-12 2.6e-08
NF1 471788 0 0 15 9 2.7e-11 6.4e-08
TRIOBP 170956 0 0 8 1 3.5e-11 7.2e-08
NBPF16 44240 0 1 4 4 2.4e-10 4.2e-07
TFAP2D 46768 0 1 5 0 2.5e-10 4.2e-07
MGRN1 53088 0 0 5 1 3.4e-09 5.4e-06
IRS1 106176 0 0 6 1 6e-09 8.2e-06
YSK4 160844 0 0 7 1 6.1e-09 8.2e-06
CRB1 162108 0 0 7 0 7.1e-09 8.9e-06
CHD4 213932 0 0 8 0 1.1e-08 0.000013
HUWE1 427232 0 1 11 2 2.1e-08 0.000024
SIGLEC12 61620 0 0 5 0 5.1e-08 0.000053
NLRP3 120080 0 0 6 1 5.4e-08 0.000053
SON 252168 0 0 8 4 8.1e-08 0.000076
QSOX2 64780 0 0 5 1 1.2e-07 0.0001
CYP11B1 52456 0 0 7 0 1.8e-07 0.00015
CRTAC1 66992 0 1 5 1 2e-07 0.00016
RB1CC1 194340 0 1 7 5 3e-07 0.00024
GPRIN3 74260 0 0 5 0 8.9e-07 0.00067
AHNAK 636108 0 1 12 0 1.1e-06 0.00079
ZNF208 147572 0 0 6 0 1.2e-06 0.00085
C9orf171 28440 0 0 5 1 1.4e-06 0.00096
DST 777992 0 3 15 2 2.4e-06 0.0015
PLB1 163056 0 0 6 0 4.4e-06 0.0028
KIT 119132 0 2 7 1 6e-06 0.0036
GRLF1 167796 0 2 6 3 6.3e-06 0.0037
SCEL 88164 0 0 5 1 8e-06 0.0046
RNF213 480320 0 1 9 1 0.000019 0.01
NCKAP5 186756 0 1 6 0 0.000021 0.011
Methods & Data
Methods

In brief, we tabulate the number of mutations and the number of covered bases for each gene. The counts are broken down by mutation context category: four context categories that are discovered by MutSig, and one for indel and 'null' mutations, which include indels, nonsense mutations, splice-site mutations, and non-stop (read-through) mutations. For each gene, we calculate the probability of seeing the observed constellation of mutations, i.e. the product P1 x P2 x ... x Pm, or a more extreme one, given the background mutation rates calculated across the dataset. [1]

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] TCGA, Integrated genomic analyses of ovarian carcinoma, Nature 474:609 - 615 (2011)